SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: S-3
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea0266812-s3_synergy.htm

Chunk 2 of 26
Word Count: 1439
Character Count: 9226

Document Content:

decrease of $8 million, or 19%, compared to net revenue for the year ended December 31, 2023 of $42.8 million. Net revenue for the nine months ended September 30, 2025 was $24.3 million, a decrease of $0.3 million, or 1% compared to net revenue of $24.6 million for the nine months ended September 30, 2024. FOCUSfactor net revenue decreased 2% from $21.3 million for the nine months ended September 30, 2024 to $20.8 million for the nine months ended September 30, 2025. FOCUSfactor net revenue for the year ended December 31, 2024 was $30.8 million, a 17.0% decrease from FOCUSfactor net revenue for the year ended December 31, 2023 of $37.2 million. During the nine months ended September 30, 2025 we also had revenue from a license agreement of $2.9 million related to expansion in selected foreign markets, which we anticipate to be an ongoing source of revenue. Our Brands

Our flagship brand, FOCUSfactor, is a brain health nutritional supplement
with over 24 years of history and a clinically-tested formula (this study was performed independently and is not related to
any FDA-approved IND application) comprised of a proprietary blend of key brain supporting ingredients along with vitamins, minerals,
and other nutrients. We believe FOCUSfactor is the only product in its category whose entire formula has been shown to support memory,
concentration and focus. Our FOCUSfactor brand consists of over 34 SKUs and is sold primarily through leading retailers in the United States,
including Costco, Walmart, Amazon.com, Walgreens, CVS, Meijer, and Albertson’s in addition to selling direct to consumer through
the FOCUSfactor website. Across three of our key partners, we have increased the number of SKUs sold through the retailer from the single
SKU available at the beginning of our relationship in 2015 or 2016. In addition, we have increased our presence in retail locations for
these key partners, resulting in a significant increase in points of distribution, being the number of SKUs multiplied by the number of
retail locations for each retailer. We have also expanded the brand internationally into Canada (2020), the UK (2023) and we anticipate
being in Mexico in the fourth quarter of 2025 and in Taiwan, Australia and Asia in 2026.

FOCUSfactor has expanded into
the beverage market with its focus plus energy RTD. According to Zion Research in January 2024, the beverage market is large
($176 billion in 2022) and growing (projected 8.6% CAGR covering eight years from 2022 through 2030) with an expanding range
of functional benefits such as energy, hydration, cognition/focus, weight loss, gut health and immunity. Examples such as Celsius and
Beyond Raw offer dual-benefit products that deliver fat burning plus energy while C4 Smart Energy and FocusAid deliver focus plus
energy. Additionally, consumers are looking for not only refreshing drinks but health perks such as zero sugar and low-calorie drinks.
This consumer shift in preferences towards more functional benefits can be seen in the evolution of the energy RTD category where originally
competitors like Red Bull and Monster delivered conventional energy, then the category offered more performance energy products with added
vitamins and amino acids in products such as Reign and C4 Performance to products with more natural energy characteristics and then to
the dual-benefit energy products that we see today.

FOCUSfactor is well-positioned to
capitalize on the evolving energy RTD category (U.S. sales of $19.2 billion in 2023 and a CAGR of 6.3% from 2018 to 2023, according
to Euromonitor in December 2023) with its new focus plus energy RTD. We believe this represents a major growth opportunity,
with our dual-benefit RTD formula offering both focus and energy behind a 24+ year brand with strong heritage and awareness in the
area of brain health. The FOCUSfactor brand name clearly communicates the differentiation benefit of adding focus to energy. The FOCUSfactor
formula does not have to rely as heavily on caffeine as other brands such as Celsius, Bang, Reign and C4, as its formula is a balanced
blend of vitamins, cognitive nutrients and caffeine all in a zero sugar, low calorie, great-tasting drink. The brand also delivers
a significant value relative to many competitors. Additionally, FOCUSfactor has long-term relationships with large retailers where
it has an established presence, which will assist in market penetration for its RTD products. FOCUSfactor is looking to attract both existing
consumers of supplement products (typically consumers over age 50) to RTDs as well as a younger demographic (aged 18-49).

FOCUSfactor has successfully
demonstrated the ability to leverage its existing retailer relationships to expand its RTDs. From March 2023 through August 2023,
FOCUSfactor conducted a five-month trial of its RTD products in 44 clubs of a warehouse club retailer throughout Texas with sales
ranging from $550 per club per week to $2,382 per club per week. From April 2024 through July 2024, a second pilot was successfully
completed at a major Canadian club retailer throughout Canada with results ranging from C$378 per club per week to C$2,206 per club per
week.

Our second marquee brand, Flat
Tummy, consists of a range of lifestyle and wellness products and accessories including tea, shakes, lollipops, supplements, apparel,
and exercise accessories. We also provide a Flat Tummy mobile app, which, as of September 30, 2025, had approximately 2 million unique
downloads and is intended as a tool to promote the Flat Tummy lifestyle centered around general wellness and health. Our Flat Tummy brand
consists of 12 SKUs and is sold direct to consumer through the Flat Tummy website and application, as well as through Amazon.com, Target.com,
and iherb.com.

We also own six additional,
non-core brands. While we may elect to promote these brands and commercialize their products in the future, we have prioritized our
key brands, FOCUSfactor and Flat Tummy, and management is focused on the growth of these core products.

Our net revenues by brand for
the nine months ended September 30, 2025 are below:

Net Revenue by Brand for the Nine Months Ended
September 30, 2025

In the United States,
the U.S. Food and Drug Administration (the “FDA”) has regulatory oversight over our FOCUSfactor and Flat Tummy products.
However, no formal FDA approval or registration is required because our products are classified as dietary supplements (most FOCUSfactor
products and some Flat Tummy products) or foods (some FOCUSfactor and Flat Tummy products).

In Canada, Health Canada (“HC”)
has oversight over our FOCUSfactor and Flat Tummy products. Our FOCUSfactor and Flat Tummy products are considered natural health products
by HC so they each have a natural product number that was assigned by HC upon its review and approval.

In the United Kingdom, both
FOCUSfactor and Flat Tummy are considered food supplements that are regulated by the Food Standards Agency. While there is no requirement
for licensing or registering food supplement products in the United Kingdom, products must comply with relevant food law.

In Australia, FOCUSfactor products
are “Listed Medicines” that are regulated by the Therapeutic Goods Administration (“TGA”) and require an AUST
L (Australia Listed Medicine) number, which has been received for some SKUs. Flat Tummy products are classified as either Listed Medicines
or meal replacements. Listed Medicines are regulated by the TGA while meal replacements are regulated under the Australia New Zealand
Food Standards Code.

Our Competitive Strengths

We believe that we have attributes
that differentiate us from our competitors and provide us with significant competitive advantages. Our key competitive strengths include:

Well-Positioned in Growing Categories
Driven by Favorable Consumer Trends

An increased focus on health, beauty and wellness by consumers has
served as a tailwind for our brands. The nutritional supplement market has experienced significant growth across a range of areas including
immune health, brain health, heart health, sleep/stress, and overall nutrition and wellness as a result of an aging population, increased
obesity, pandemic concerns and a desire for more natural solutions and treatments over prescription medication. We believe that we are
well positioned to benefit from these favorable trends. The brain health segment is slated to grow at 8% per year in the United States
and 13% per year globally through 2030, according to Grand View Research. We believe our focus on lifestyle products has also benefited
from the growth and prevalence of social media.

Results Backed by Independent Study for
FOCUSfactor

We believe the FOCUSfactor
brand is strengthened by an independent clinical study to support the product claims for improved memory, concentration, and focus. FOCUSfactor
has been tested in a single-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate its effect on memory,
concentration, and focus in healthy adults. The study was not a clinical trial conducted pursuant to an FDA-approved IND application,
and the FDA has not reviewed this study or evaluated these performance claims.